Logo image of BCS

BARCLAYS PLC-SPONS ADR (BCS) Stock Fundamental Analysis

NYSE:BCS - US06738E2046 - ADR

19.63 USD
-0.4 (-2%)
Last: 8/29/2025, 8:07:53 PM
19.6 USD
-0.03 (-0.15%)
After Hours: 8/29/2025, 8:07:53 PM
Fundamental Rating

3

Taking everything into account, BCS scores 3 out of 10 in our fundamental rating. BCS was compared to 395 industry peers in the Banks industry. BCS has a bad profitability rating. Also its financial health evaluation is rather negative. BCS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BCS was profitable.
BCS had a negative operating cash flow in the past year.
Each year in the past 5 years BCS has been profitable.
Of the past 5 years BCS 4 years had a positive operating cash flow.
BCS Yearly Net Income VS EBIT VS OCF VS FCFBCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.33%, BCS is doing worse than 81.57% of the companies in the same industry.
Looking at the Return On Equity, with a value of 7.00%, BCS is doing worse than 62.12% of the companies in the same industry.
Industry RankSector Rank
ROA 0.33%
ROE 7%
ROIC N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
BCS Yearly ROA, ROE, ROICBCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

BCS has a worse Profit Margin (17.31%) than 69.19% of its industry peers.
In the last couple of years the Profit Margin of BCS has grown nicely.
The Operating Margin and Gross Margin are not available for BCS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 17.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.74%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
BCS Yearly Profit, Operating, Gross MarginsBCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

1

2. Health

2.1 Basic Checks

BCS does not have a ROIC to compare to the WACC, probably because it is not profitable.
BCS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BCS has less shares outstanding
Compared to 1 year ago, BCS has about the same debt to assets ratio.
BCS Yearly Shares OutstandingBCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
BCS Yearly Total Debt VS Total AssetsBCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

A Debt/Equity ratio of 3.86 is on the high side and indicates that BCS has dependencies on debt financing.
BCS has a worse Debt to Equity ratio (3.86) than 94.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.85%
BCS Yearly LT Debt VS Equity VS FCFBCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BCS Yearly Current Assets VS Current LiabilitesBCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.12% over the past year.
The Earnings Per Share has been growing by 11.00% on average over the past years. This is quite good.
The Revenue has been growing slightly by 5.48% in the past year.
The Revenue has been growing slightly by 5.03% on average over the past years.
EPS 1Y (TTM)42.12%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%51.32%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.87%
Revenue growth 5Y5.03%
Sales Q2Q%13.65%

3.2 Future

The Earnings Per Share is expected to grow by 7.87% on average over the next years.
The Revenue is expected to grow by 3.46% on average over the next years.
EPS Next Y8.58%
EPS Next 2Y15.2%
EPS Next 3Y14.7%
EPS Next 5Y7.87%
Revenue Next Year8.41%
Revenue Next 2Y6.45%
Revenue Next 3Y5.44%
Revenue Next 5Y3.46%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BCS Yearly Revenue VS EstimatesBCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
BCS Yearly EPS VS EstimatesBCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.67, the valuation of BCS can be described as very cheap.
Based on the Price/Earnings ratio, BCS is valued cheaply inside the industry as 94.19% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.13. BCS is valued rather cheaply when compared to this.
BCS is valuated cheaply with a Price/Forward Earnings ratio of 6.71.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BCS indicates a rather cheap valuation: BCS is cheaper than 92.93% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.76. BCS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.67
Fwd PE 6.71
BCS Price Earnings VS Forward Price EarningsBCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCS Per share dataBCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

BCS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BCS's earnings are expected to grow with 14.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)0.7
EPS Next 2Y15.2%
EPS Next 3Y14.7%

More info and screens

4

5. Dividend

5.1 Amount

BCS has a Yearly Dividend Yield of 2.31%.
BCS's Dividend Yield is slightly below the industry average, which is at 3.17.
BCS's Dividend Yield is comparable with the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

The dividend of BCS is nicely growing with an annual growth rate of 6.61%!
BCS has been paying a dividend for at least 10 years, so it has a reliable track record.
BCS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.61%
Div Incr Years3
Div Non Decr Years3
BCS Yearly Dividends per shareBCS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

BCS's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DPN/A
EPS Next 2Y15.2%
EPS Next 3Y14.7%
BCS Yearly Income VS Free CF VS DividendBCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B

More info and screens

BARCLAYS PLC-SPONS ADR

NYSE:BCS (8/29/2025, 8:07:53 PM)

After market: 19.6 -0.03 (-0.15%)

19.63

-0.4 (-2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-22 2025-10-22
Inst Owners51.51%
Inst Owner Change3.08%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap68.93B
Analysts79.05
Price Target22.49 (14.57%)
Short Float %0.43%
Short Ratio0.95
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Yearly Dividend0.87
Dividend Growth(5Y)6.61%
DPN/A
Div Incr Years3
Div Non Decr Years3
Ex-Date08-08 2025-08-08 (0.159876)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.23%
Min EPS beat(2)13.75%
Max EPS beat(2)16.7%
EPS beat(4)4
Avg EPS beat(4)29.84%
Min EPS beat(4)13.75%
Max EPS beat(4)64.16%
EPS beat(8)8
Avg EPS beat(8)28.97%
EPS beat(12)12
Avg EPS beat(12)22.72%
EPS beat(16)16
Avg EPS beat(16)27.45%
Revenue beat(2)2
Avg Revenue beat(2)2.74%
Min Revenue beat(2)1.38%
Max Revenue beat(2)4.11%
Revenue beat(4)4
Avg Revenue beat(4)2.75%
Min Revenue beat(4)1.38%
Max Revenue beat(4)4.11%
Revenue beat(8)6
Avg Revenue beat(8)1.21%
Revenue beat(12)9
Avg Revenue beat(12)12.13%
Revenue beat(16)13
Avg Revenue beat(16)26.31%
PT rev (1m)8.88%
PT rev (3m)15.11%
EPS NQ rev (1m)-3.49%
EPS NQ rev (3m)-9.39%
EPS NY rev (1m)-1.59%
EPS NY rev (3m)-0.78%
Revenue NQ rev (1m)-1.93%
Revenue NQ rev (3m)-1.46%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)0.93%
Valuation
Industry RankSector Rank
PE 7.67
Fwd PE 6.71
P/S 1.67
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.76
EV/EBITDA N/A
EPS(TTM)2.56
EY13.04%
EPS(NY)2.92
Fwd EY14.89%
FCF(TTM)-3.89
FCFYN/A
OCF(TTM)-3.89
OCFYN/A
SpS11.76
BVpS29.07
TBVpS25.94
PEG (NY)0.89
PEG (5Y)0.7
Profitability
Industry RankSector Rank
ROA 0.33%
ROE 7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 17.31%
GM N/A
FCFM N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.74%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC5.85%
ROIC/WACCN/A
Cap/Depr(3y)89.52%
Cap/Depr(5y)85.55%
Cap/Sales(3y)5.72%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.12%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%51.32%
EPS Next Y8.58%
EPS Next 2Y15.2%
EPS Next 3Y14.7%
EPS Next 5Y7.87%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.87%
Revenue growth 5Y5.03%
Sales Q2Q%13.65%
Revenue Next Year8.41%
Revenue Next 2Y6.45%
Revenue Next 3Y5.44%
Revenue Next 5Y3.46%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.18%
FCF growth 3Y-51.04%
FCF growth 5YN/A
OCF growth 1Y-25.18%
OCF growth 3Y-47.42%
OCF growth 5YN/A